Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R) Demonstrating Statistically Significant …
Topical treatments offer effective local pain relief
Read more on New Kerala
Washington, June 16 : Gels, creams and sprays containing painkillers such as ibuprofen, diclofenac, ketoprofen, and piroxicam are safe and effective treatments for local pain, according to researchers.Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R) Demonstrating Statistically Significant …
Read more on redOrbit
NORTHBROOK, Ill., June 16 /PRNewswire/ — Horizon Pharma, Inc., announced today that data from the Phase 3 U.S.Global Peptic Ulcer Testing industry
Read more on PR Newswire via Yahoo! Finance
Reportlinker.com announces that a new market research report is available in its catalogue:Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R) Demonstrating Statistically Significant …
Read more on SYS-CON Media
- LODOTRA Demonstrates Sustained Efficacy and Safety in Rheumatoid Arthritis Patients for up to 12-months – read moreHorizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R) Demonstrating Statistically Significant …
Read more on PR Newswire via Yahoo! Finance
Horizon Pharma, Inc., announced today that data from the Phase 3 U.S. registration study of LODOTRA®, a circadian cytokine modulator and novel modified-release, low-dose prednisone tablet, showed a statistically significant improvement in American College of Rheumatology response criteria in patients with rheumatoid arthritis .  These data, along with 12-month efficacy data from the company’s …
Leave a Comment